NDC 44567-507

Teniposide

Teniposide

Teniposide is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Wg Critical Care, Llc. The primary component is Teniposide.

• Product ID: 44567-507_66e065ad-bd6c-4f67-a322-6a548cf11f5e
• NDC: 44567-507
• Product Type: Human Prescription Drug
• Proprietary Name: Teniposide
• Generic Name: Teniposide
• Dosage Form: Injection, Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2013-04-30
• Marketing Category: NDA / NDA
• Application Number: NDA020119
• Labeler Name: WG Critical Care, LLC
• Substance Name: TENIPOSIDE
• Active Ingredient Strength: 10 mg/mL
• Pharm Classes: Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 44567-507-01

1 AMPULE in 1 CARTON (44567-507-01) > 5 mL in 1 AMPULE

• Marketing Start Date: 2013-04-30
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 44567-507-01 [44567050701]

Teniposide INJECTION, SOLUTION

• Marketing Category: NDA
• Application Number: NDA020119
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2013-04-30

Drug Details

Active Ingredients

Ingredient	Strength
TENIPOSIDE	10 mg/mL

OpenFDA Data

• SPL SET ID: f19cf6d7-a1c8-42ec-844c-c798512139d9
• Manufacturer:
  • WG Critical Care, LLC
• UNII:
  • 957E6438QA
• RxNorm Concept Unique ID - RxCUI:
  • 313213
• UPC Code:
  • 0344567507016

Pharmacological Class

• Topoisomerase Inhibitor [EPC]
• Topoisomerase Inhibitors [MoA]